Logo-apb
Adv Pharm Bull. 2022;12(2): 298-308. doi: 10.34172/apb.2022.041
PMID: 35620346        PMCID: PMC9106966

Review Article

Solid Lipid Nanoparticles for Efficient Oral Delivery of Tyrosine Kinase Inhibitors: A Nano Targeted Cancer Drug Delivery

Sukanta Satapathy 1 * ORCID, Chandra Sekhar Patro 1 ORCID

Cited by CrossRef: 4


1- Iqbal S, Schneider T, Truong T, Ulrich-Müller R, Nguyen P, Ilyas S, Mathur S. Carriers for hydrophobic drug molecules: lipid-coated hollow mesoporous silica particles, and the influence of shape and size on encapsulation efficiency. Nanoscale. 2024;16(23):11274 [Crossref]
2- Kostrzewa T, Nowak I, Feliczak-Guzik A, Drzeżdżon J, Jacewicz D, Górska-Ponikowska M, Kuban-Jankowska A. Encapsulated Oxovanadium(IV) and Dioxovanadium(V) Complexes into Solid Lipid Nanoparticles Increase Cytotoxicity Against MDA-MB-231 Cell Line. IJN. 2023;Volume 18:2507 [Crossref]
3- Kollipara S, Chougule M, Boddu R, Bhatia A, Ahmed T. Playing Hide-and-Seek with Tyrosine Kinase Inhibitors: Can We Overcome Administration Challenges?. AAPS J. 2024;26(4) [Crossref]
4- Safaie N, Idari G, Ghasemi D, Hajiabbasi M, Alivirdiloo V, Masoumi S, Zavvar M, Majidi Z, Faridvand Y. AMPK activation; a potential strategy to mitigate TKI-induced cardiovascular toxicity. Archives of Physiology and Biochemistry. 2024;:1 [Crossref]
5- Nasr M, Mokhtar R, Abdel-rashid R. Optimized PEGylated cubosomes: a novel approach for specific delivery of dacomitinib to non-small cell lung cancer cells. Mater Adv. 2025; [Crossref]
6- Jana M, Patro C, Sharma S, Naskar S, Biswas U, Debnath B. Development and evaluation of solid lipid nanoparticles for enhanced peroral bioavailability of capecitabine. Journal of Biomaterials Science, Polymer Edition. 2025;:1 [Crossref]
7- Nemati S, Mottaghi M, Karami P, Mirjalali H. Development of solid lipid nanoparticles-loaded drugs in parasitic diseases. Discover Nano. 2024;19(1) [Crossref]